PRICE T ROWE ASSOCIATES INC /MD/ - TRANSLATE BIO INC ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$25,094,000
-15.8%
911,191
-49.6%
0.00%
-33.3%
Q1 2021$29,788,000
-17.9%
1,806,445
-8.3%
0.00%
-25.0%
Q4 2020$36,287,000
+45.7%
1,968,931
+7.6%
0.00%
+33.3%
Q3 2020$24,897,000
-28.5%
1,829,295
-5.8%
0.00%
-25.0%
Q2 2020$34,807,000
+2122.7%
1,942,373
+1136.7%
0.00%
Q1 2020$1,566,000
+13.0%
157,064
-7.7%
0.00%
Q4 2019$1,386,000170,2090.00%
Other shareholders
TRANSLATE BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 2,656,517$48,960,00010.98%
Copernicus Capital Management, LLC 12,091$223,0003.48%
FRAZIER MANAGEMENT LLC 2,182,789$40,229,0003.10%
Baupost Group 18,044,239$326,236,0003.01%
DAFNA Capital Management LLC 225,393$4,154,0001.24%
RTW INVESTMENTS, LP 2,978,427$54,892,0000.92%
MARATHON CAPITAL MANAGEMENT 143,275$2,640,0000.78%
Bain Capital Public Equity Management II, LLC 627,387$11,563,0000.59%
Artal Group S.A. 1,200,000$22,116,0000.48%
Birchview Capital, LP 30,000$553,0000.32%
View complete list of TRANSLATE BIO INC shareholders